Alendronate and vertebral fracture risk [4] (multiple letters)

Mayo Clinic Proceedings

Volumn 80, Issue 9, 2005, Pages 1236-1240

  Mikhail, Nasser ^a   Cope, Dennis ^a   Seeman, Ego ^b   Quandt, Sara A ^c   Thompson, Desmond E ^d   Schneider, Diane L ^e   Nevitt, Michael C ^f  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PLACEBO;

AGED; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DRUG INDICATION; FEMALE; FEMUR NECK; FRACTURE; HUMAN; LETTER; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; RISK ASSESSMENT; STATISTICAL ANALYSIS; VERTEBRA FRACTURE; HIP FRACTURE; INCIDENCE; NOTE; RECURRENT DISEASE; SPINE FRACTURE; RISK FACTOR;

ALENDRONATE; BONE DENSITY; DATA INTERPRETATION, STATISTICAL; FEMALE; FEMUR NECK; HIP FRACTURES; HUMANS; INCIDENCE; RECURRENCE; SPINAL FRACTURES; OSTEOPOROSIS; RISK FACTORS;

EID: 24144499121     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/80.9.1236     Document Type: Letter

References (4)

1. SA Quandt DE Thompson DL Schneider Fracture Intervention Trial Research Group Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of -1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial Mayo Clin Proc 80 2005 343 349
2. JA Cauley J Robbins Z Chen Women's Health Initiative Investigators Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative Randomized Trial JAMA 290 2003 1729 1738
3. PD Miller S Barlas SK Brenneman An approach to identifying osteopenic women at increased short-term risk of fracture Arch Intern Med 164 2004 1113 1120
4. SR Cummings LJ Melton Epidemiology and outcomes of osteoporotic fractures Lancet 359 2002 1761 1767